Total Payments
$12,152
2024 Payments
$696.05
Companies
51
Transactions
304
Medicare Patients
9,700
Medicare Billing
$459,674
Payment Breakdown by Category
Education$6,287 (51.7%)
Food & Beverage$5,191 (42.7%)
Travel$673.12 (5.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $6,287 | 18 | 51.7% |
| Food and Beverage | $5,191 | 281 | 42.7% |
| Travel and Lodging | $673.12 | 5 | 5.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $6,459 | 10 | $0 (2022) |
| ABBVIE INC. | $1,086 | 55 | $0 (2024) |
| Novo Nordisk Inc | $643.11 | 44 | $0 (2024) |
| Astellas Pharma US Inc | $573.08 | 32 | $0 (2024) |
| Boston Scientific Corporation | $478.36 | 3 | $0 (2023) |
| AMAG Pharmaceuticals, Inc. | $298.91 | 15 | $0 (2019) |
| Axonics, Inc. | $291.60 | 4 | $0 (2024) |
| PFIZER INC. | $228.01 | 17 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $189.12 | 12 | $0 (2023) |
| Exeltis, USA Inc. | $186.96 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $696.05 | 35 | Novo Nordisk Inc ($217.12) |
| 2023 | $1,419 | 45 | Boston Scientific Corporation ($478.36) |
| 2022 | $4,297 | 64 | Intuitive Surgical, Inc. ($3,062) |
| 2021 | $3,645 | 22 | Intuitive Surgical, Inc. ($3,374) |
| 2020 | $159.55 | 11 | AbbVie Inc. ($41.39) |
| 2019 | $652.84 | 40 | AbbVie, Inc. ($136.42) |
| 2018 | $645.77 | 39 | AMAG Pharmaceuticals, Inc. ($235.53) |
| 2017 | $636.28 | 48 | Astellas Pharma US Inc ($136.96) |
All Payment Transactions
304 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Obesity | ||||||
| 12/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Biological | ||||||
| 12/05/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: WOMENS HEALTH | ||||||
| 11/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $32.46 | General |
| Category: Obesity | ||||||
| 10/30/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: CONTRACEPTIVE | ||||||
| 10/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: Obesity | ||||||
| 10/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Obesity | ||||||
| 10/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Oncology | ||||||
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: Obesity | ||||||
| 09/05/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: WOMENS HEALTH | ||||||
| 08/28/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: CONTRACEPTIVE | ||||||
| 08/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Oncology | ||||||
| 08/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Biological | ||||||
| 08/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $3.84 | General |
| Category: Biological | ||||||
| 08/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Biological | ||||||
| 07/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Obesity | ||||||
| 07/25/2024 | Aspira Women's Health Inc | OVA1 (Device) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: OB/GYN | ||||||
| 07/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Obesity | ||||||
| 07/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Obesity | ||||||
| 07/11/2024 | Channel Medsystems, Inc. | — | Food and Beverage | Cash or cash equivalent | $5.39 | General |
| 06/11/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $86.16 | General |
| Category: Urology | ||||||
| 05/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Bone Health | ||||||
| 05/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Biological | ||||||
| 04/25/2024 | Organon Llc | — | Food and Beverage | In-kind items and services | $10.17 | General |
| 04/24/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 2,836 | 2,967 | $447,971 | $140,458 |
| 2022 | 13 | 2,443 | 2,571 | $353,650 | $116,958 |
| 2021 | 16 | 2,402 | 2,473 | $327,826 | $113,429 |
| 2020 | 14 | 2,019 | 2,080 | $256,913 | $88,829 |
Total Patients
9,700
Total Services
10,091
Medicare Billing
$459,674
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Office | 2023 | 374 | 374 | $125,825 | $43,756 | 34.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 247 | 253 | $45,900 | $20,897 | 45.5% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 374 | 374 | $56,530 | $18,517 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 284 | 311 | $38,655 | $17,171 | 44.4% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 183 | 183 | $13,085 | $7,360 | 56.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 207 | 207 | $78,380 | $7,240 | 9.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 190 | 190 | $11,720 | $7,062 | 60.3% |
| 76641 | Complete ultrasound scan of 1 breast | Office | 2023 | 65 | 65 | $36,180 | $6,663 | 18.4% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 301 | 301 | $15,050 | $4,680 | 31.1% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 24 | 29 | $8,975 | $2,214 | 24.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $4,605 | $1,823 | 39.6% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 489 | 492 | $3,936 | $1,138 | 28.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 108 | $6,480 | $1,015 | 15.7% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 53 | 53 | $2,650 | $921.97 | 34.8% |
| 77067 | Screening mammography | Office | 2022 | 311 | 311 | $97,965 | $36,219 | 37.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 257 | 277 | $30,470 | $15,368 | 50.4% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 311 | 311 | $46,650 | $15,203 | 32.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 172 | 175 | $28,000 | $13,532 | 48.3% |
| 76641 | Complete ultrasound scan of 1 breast | Office | 2022 | 64 | 91 | $35,280 | $7,477 | 21.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 162 | 162 | $10,530 | $6,468 | 61.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 160 | 160 | $8,000 | $5,916 | 74.0% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2022 | 362 | 362 | $18,100 | $5,678 | 31.4% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 156 | 156 | $58,500 | $5,286 | 9.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $5,115 | $2,270 | 44.4% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 18 | 21 | $6,300 | $1,762 | 28.0% |
About Dr. C Chance, MD
Dr. C Chance, MD is a Obstetrics & Gynecology healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013022029.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. C Chance, MD has received a total of $12,152 in payments from pharmaceutical and medical device companies, with $696.05 received in 2024. These payments were reported across 304 transactions from 51 companies. The most common payment nature is "Education" ($6,287).
As a Medicare-enrolled provider, Chance has provided services to 9,700 Medicare beneficiaries, totaling 10,091 services with total Medicare billing of $459,674. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Augusta, GA
- Active Since 08/20/2006
- Last Updated 11/20/2012
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1013022029
Products in Payments
- Da Vinci Surgical System (Device) $3,459
- DAVINCI XI (Device) $3,000
- Saxenda (Drug) $370.08
- Axonics (Device) $291.60
- INTRAROSA (Drug) $273.09
- Wegovy (Drug) $273.03
- ORILISSA (Drug) $260.03
- CONTRAVE (Drug) $244.83
- LO LOESTRIN FE (Drug) $242.89
- Veozah (Drug) $234.61
- BOTOX (Biological) $215.10
- Myrbetriq (Drug) $188.47
- SLYND (Drug) $186.96
- Orilissa (Drug) $151.17
- Kyleena (Drug) $148.51
- LILETTA (Drug) $141.76
- PREMARIN (Drug) $135.29
- IMVEXXY (Drug) $107.26
- OVA1 (Device) $96.92
- TRUCLEAR (Device) $83.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Augusta
Dr. Murray Freedman, Md, MD
Obstetrics & Gynecology — Payments: $93,805
Obstetrics & Gynecology $93,805
Michael Rausch, M.d, M.D
Obstetrics & Gynecology — Payments: $89,995
Obstetrics & Gynecology $89,995
Dr. Hatim Lukman, Md, MD
Obstetrics & Gynecology — Payments: $8,395
Obstetrics & Gynecology $8,395
Dr. Donald Burns, Md, MD
Obstetrics & Gynecology — Payments: $7,924
Obstetrics & Gynecology $7,924
Dr. William Barfield, Md, MD
Obstetrics & Gynecology — Payments: $6,830
Obstetrics & Gynecology $6,830
Dr. William Lavigne, M.d, M.D
Obstetrics & Gynecology — Payments: $6,648
Obstetrics & Gynecology $6,648